News
Crystal Pharmatech | Reflecting on 2025
21 Feb 2026
en
Focus on PROTAC Compounds: Development Strategy
This series looks at the physicochemical challenges of PROTAC compounds. It explains how polymorph screening, salt/cocrystal optimization, and formulation and dosage-form development can improve solub...
.webp "Enhancing Drug Product Performance Through Spray Drying Parameter Optimization")
Enhancing Drug Product Performance Through Spray Drying Parameter Optimization
As amorphous solid dispersions (ASDs) and their formulations advance from lab-scale research to clinical trials and, ultimately, to commercial production, manufacturing scales increase from grams to k...
Solid-State, Crystallization, and CMC Control for Drug Development – A Crystal Pharmatech Case Study Series
From early developability to late-stage specifications—polymorph/salt-cocrystal strategy, SCXRD/MicroED solutions, solvent & pathway design, drug-product form control, ASD crystalline-form limits...
_.webp "A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs")
Subscribe to be the first to get the updates!
